Clinical Trials Browser

Phase 2 × Metronidazole × Gastrointestinal × Clear all

NCT06356597 2026-02-24

Tislelizumab With Fruquintinib, Metronidazole, in Mismatch Repair-proficient or Microsatellite Stability, Advanced Colorectal Cancer: a Multicenter, Single Arm, Clinical Trial

Phase 2 Active not recruiting

Gastrointestinal

Colorectal Neoplasms

NCT06728072 2026-02-09

Addition of Antibiotics to Upfront Treatment Regimen for Colorectal Cancer

Phase 2 Recruiting

Gastrointestinal

Colorectal Neoplasms

NCT04729322 2025-12-23

Fecal Microbiota Transplant and Re-introduction of Anti-PD-1 Therapy (Pembrolizumab or Nivolumab) for the Treatment of Metastatic Colorectal Cancer in Anti-PD-1 Non-responders

Phase 2 Active not recruiting

Gastrointestinal

Colorectal Neoplasms

NCT06569368 2025-10-06

Trial Utilizing Metronidazole to Optimize the Microbiome of Rectal Adenocarcinoma Undergoing Neoadjuvant Therapy

Phase 2 Recruiting

Gastrointestinal

Rectal Neoplasms

NCT06793137 2025-01-29

Intestinal Microbiome Modulation With Antibiotics in the Neoadjuvant Treatment of Locally Advanced Rectal Cancer

Phase 2 Recruiting

Gastrointestinal

Rectal Neoplasms

NCT05462496 2024-10-15

Modulation of the Gut Microbiome With Pembrolizumab Following Chemotherapy in Resectable Pancreatic Cancer

Phase 2 Recruiting

Gastrointestinal

Pancreatic Neoplasms

NCT04312360 2023-09-07

MEFO

Phase 2 Completed

Gastrointestinal

Colonic Neoplasms

NCT02682485 2023-04-26

SES-DTA

Phase 2 Withdrawn

Gastrointestinal

Rectal Neoplasms, Anastomotic Leak

NCT05720559 2023-02-09

Early Blocking Strategy for Metachronous Liver Metastasis of Colorectal Cancer Based on Pre-hepatic CTC Detection

Phase 2 Not yet recruiting

Gastrointestinal

Preventive Effect of Quintuple Therapy on Metachronous Liver Metastases in Patients With Colorectal Cancer

NCT04264676 2020-11-25

Study of Oral Metronidazole on Postoperative Chemotherapy in Colorectal Cancer

Phase 2 Unknown

Gastrointestinal

Colorectal Neoplasms